Takeo Ishiyama

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Takeo Ishiyama et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 433 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test

Takeo Ishiyama, Tadashi Ishibashi, Akira Itô et al. · European Journal of Pharmacology · 2007 · 164 citations

Medicine, Neuroscience, Pharmacology +10

Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats

Takeshi Enomoto, T Ishibashi, Koki Tokuda et al. · Behavioural Brain Research · 2007 · 129 citations

Medicine, Neuroscience, Pharmacology +13

The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: Mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone

Tomoko Horisawa, Tadashi Ishibashi, Hiroyuki Nishikawa et al. · Behavioural Brain Research · 2011 · 76 citations

Medicine, Neuroscience, Pharmacology +14

The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone

Tomoko Horisawa, Hiroyuki Nishikawa, Satoko Toma et al. · Behavioural Brain Research · 2013 · 55 citations

Medicine, Neuroscience, Pharmacology +11